Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports
S Moffa, I Improta, S Rocchetti, T Mezza, A Giaccari - Nutrition, 2019 - Elsevier
… Both tests showed very high insulin levels with no concomitant C-peptide elevation and excluded
the possibility of increased endogenous insulin secretion … Insulin (μIU/mL), 137, 171, 222, 254,
285, 286, 239, 197. C-peptide (ng/mL), 2.7, 5.8, 9.3, 7.8, 8.7, 11.3, 7.4, 3.4 …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com
S Moffa, I Improta, S Rocchetti, T Mezza, A Giaccari - Nutrition, 2019 - Elsevier
… Both tests showed very high insulin levels with no concomitant C-peptide elevation and excluded
the possibility of increased endogenous insulin secretion … Insulin (μIU/mL), 137, 171, 222, 254,
285, 286, 239, 197. C-peptide (ng/mL), 2.7, 5.8, 9.3, 7.8, 8.7, 11.3, 7.4, 3.4 …
the possibility of increased endogenous insulin secretion … Insulin (μIU/mL), 137, 171, 222, 254,
285, 286, 239, 197. C-peptide (ng/mL), 2.7, 5.8, 9.3, 7.8, 8.7, 11.3, 7.4, 3.4 …
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论